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Virulence Gene Regulation by CvfA, a Putative RNase: the CvfA-Enolase
Complex in Streptococcus pyogenes Links Nutritional Stress,
Growth-Phase Control, and Virulence Gene Expression†
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Molecular Microbiology, Washington University School of Medicine, Box 8230, St. Louis, Missouri 63110-10932
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Streptococcus pyogenes, a multiple-auxotrophic human pathogen, regulates virulence gene expression accord-
ing to nutritional availability during various stages in the infection process or in different infection sites. We
discovered that CvfA influenced the expression of virulence genes according to growth phase and nutritional
status. The influence of CvfA in C medium, rich in peptides and poor in carbohydrates, was most pronounced
at the stationary phase. Under these conditions, up to 30% of the transcriptome exhibited altered expression;
the levels of expression of multiple virulence genes were altered, including the genes encoding streptokinase,
CAMP factor, streptolysin O, M protein (more abundant in the CvfA mutant), SpeB, mitogenic factor, and
streptolysin S (less abundant). The increase of carbohydrates or peptides in media restored the levels of
expression of the virulence genes in the CvfA mutant to wild-type levels (emm, ska, and cfa by carbohydrates;
speB by peptides). Even though the regulation of gene expression dependent on nutritional stress is commonly
linked to the stringent response, the levels of ppGpp were not altered by deletion of cvfA. Instead, CvfA
interacted with enolase, implying that CvfA, a putative RNase, controls the transcript decay rates of virulence
factors or their regulators according to nutritional status. The virulence of CvfA mutants was highly
attenuated in murine models, indicating that CvfA-mediated gene regulation is necessary for the pathogenesis
of S. pyogenes. Taken together, the CvfA-enolase complex in S. pyogenes is involved in the regulation of virulence
gene expression by controlling RNA degradation according to nutritional stress.
Streptococcus pyogenes is a strict human pathogen that
causes a variety of diseases ranging from mild superficial in-
fections, such as impetigo and pharyngitis, to life-threatening
systemic diseases, such as toxic shock and necrotizing fasciitis.
The primary infection sites of S. pyogenes are the upper respi-
ratory mucosal epithelium and the superficial layers of the
epidermis. On rare occasions, S. pyogenes causes severe inva-
sive diseases by penetrating the bloodstream or deep tissue.
Some infection sites, such as blood, provide a rich source of
nutrients, but others, such as plasma and the interstitial tissue
fluid, are not nutritionally rich in terms of free amino acids,
inorganic phosphate, and glucose (36). Nutrients would be
more limited when S. pyogenes comes into contact with the skin
or throat as the primary infection site. Because each of the
infection sites provides a unique nutritional environment, S.
pyogenes must alter its virulence gene expression pattern by
sensing nutrient availability in order to obtain more nutrients
in each infection site.
The major regulatory molecules responding to nutrient star-
vation, especially amino acid starvation, are guanosine nucle-
otides, mainly guanosine tetraphosphate (ppGpp). Under con-
ditions of nutritional stress, accumulation of ppGpp initiates a
global change in cellular metabolism, a phenomenon termed
the stringent response, which includes the downregulation of
nucleic acid and protein syntheses, and the simultaneous up-
regulation of protein degradation and amino acid synthesis
(27). Many virulence genes mostly involved in host protein
degradation and peptide uptake in S. pyogenes are upregulated
during amino acid starvation (36). This upregulation, however,
is independent of RelA, which is the only enzyme to synthesize
or hydrolyze guanosine tetraphosphate (ppGpp) in S. pyogenes.
This implies that a new pathway to regulate virulence gene
expression other than ppGpp-mediated stringent response un-
der nutrient starvation conditions exists in S. pyogenes. Patho-
gens like S. pyogenes, which is a multiple-amino-acid auxo-
troph, are likely to use a strategy different from that of
nonpathogenic microorganisms to survive under nutrient-lim-
ited conditions. In addition to applying the general stringent
response, which downregulates metabolic processes, S. pyo-
genes appears to adopt an active strategy by increasing the
expression of virulence factors, such as the major secreted
protease SpeB to obtain essential amino acids in tissues (8, 14,
21, 44).
During the study of a transposon-generated CvfA (SPy_1633) null
mutant, we discovered that CvfA regulated the expression of
virulence factors according to growth phase and nutritional
status. The cvfA (conserved virulence factor A) gene was
previously identified as a gene affecting the virulence of
Staphylococcus aureus through a silkworm infection model
and a mouse intraperitoneal infection model (17). CvfA has
been studied in only two bacteria, Staphylococcus aureus and
Bacillus subtilis. CvfA has three distinctive domains: a trans-
membrane domain at the N terminus, a KH (ribonucleopro-
* Corresponding author. Mailing address: Department of Microbi-
ology, Southern Illinois University Carbondale, 1125 Lincoln Drive,
Room 131, Mail code 6508, Carbondale, IL 62901-6508. Phone: (618)
453-3817. E-mail: cho@micro.siu.edu.
† Supplemental material for this article may be found at http://iai
.asm.org/.
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tein K homology) domain in the middle, which has RNA
binding activity (42), and an HD (His-Asp-containing phos-
phohydrolase) domain in the C-terminal region, known to
have metal-dependent phosphohydrolase activity (2). The
CvfA ortholog in B. subtilis, which has been named YmdA
(16), Rny (10), or RNase Y (35), is located on the cell
membrane, probably through its N-terminal transmembrane
domain (16). The KH and HD domains are required for viru-
lence of S. aureus in the silkworm model, indicating that these
motifs have an important role in CvfA function (17, 29).
Previously, on the basis of the existence of its domains, CvfA
was postulated to be an RNase (1), and recent studies verified
that CvfA is an endoribonuclease. YmdA, the CvfA ortholog in
B. subtilis, is responsible for the endonucleolytic processing of
the gapA operon mRNA, which encodes six genes in the gly-
colytic pathway (cggR, gapA, pgk, tpiA, pgm, and eno) (10).
YmdA cleaves the gapA operon mRNA between cggR and
gapA. YmdA also cleaves the 5monophosphorylated S-adeno-
sylmethionine (SAM)-dependent riboswitches, and the deple-
tion of YmdA increases the half-life of bulk mRNA more than
2-fold, indicating that YmdA is important for the initiation of
mRNA decay as well as for riboswitch RNA turnover in B.
subtilis (35). In addition, YmdA interacts with glycolytic en-
zymes phosphofructokinase and enolase (10). We also verified
the interaction between CvfA and enolase in S. pyogenes.
Taken together, a protein complex containing CvfA and eno-
lase regulates the expression of virulence genes, and the reg-
ulation is dependent on the nutritional status of S. pyogenes.
Most previously known regulatory mechanisms for the expres-
sion of virulence factors in S. pyogenes are mediated by tran-
scriptional regulators (19). However, the CvfA-involved regu-
latory system appears to use a new mechanism to regulate the
expression of virulence factors at the posttranscriptional level.
MATERIALS AND METHODS
Bacterial strains and media. All experiments and strain construction em-
ployed Streptococcus pyogenes HSC5 (15). Molecular cloning experiments uti-
lized Escherichia coli DH5 which was cultured in Luria-Bertani broth (34).
Routine culture of S. pyogenes employed Todd-Hewitt medium (BBL) supple-
mented with 0.2% yeast extract (Difco) (THY medium) with incubation at 37°C
in sealed tubes without agitation. Unless indicated otherwise, growth of S. pyo-
genes for SpeB activity assay, Western blotting, and RNA preparation for mi-
croarray and real-time PCR used C medium (25). To produce solid media, Bacto
agar (Difco) was added to a final concentration of 1.4% (wt/vol). Cultures on
solid media were incubated under the anaerobic conditions produced using a
commercial gas generator (GasPak) (catalogue no. 260678; BBL). A chemically
defined S. pyogenes medium (CDM) (43) was modified by supplementation with
0.1% yeast extract (CDMY) to improve growth of culture inoculated with
washed cells (23). To increase the amount of nitrogen source in the CDMY
medium, dialyzed peptides (1%, wt/vol) were added to CDMY medium contain-
ing 0.05% glucose. Bacto proteose peptone no. 3 (BD Diagnostic Systems) was
dialyzed at 4°C for 48 h with 10,000-molecular-weight cutoff (MWCO) dialysis
tubing (SnakeSkin dialysis tubing; Pierce). Double deionized water (5 liters) was
replaced every 12 h during dialysis. When appropriate, antibiotics were added to
the media at the following concentrations if they are not specified; spectinomy-
cin, 100 g/ml for E. coli and S. pyogenes; kanamycin, 50 g/ml for E. coli and 500
g/ml for S. pyogenes.
Manipulation of DNA. Plasmid DNA was isolated by standard techniques and
used to transform E. coli by the method of Lederberg and Cohen (20) and to
transform S. pyogenes by electroporation as described previously (6). Restriction
endonucleases, ligases, and polymerases were used according to the recommen-
dations of the manufacturers. Chromosomal DNA was purified from S. pyogenes
as described previously (6). When required, DNA fragments were purified using
MinElute gel extraction kit (Qiagen) following electrophoresis through an aga-
rose gel.
Strain construction. The CvfA mutant strain contains insertional disruption
of cvfA and was derived from S. pyogenes HSC5 as follows. An internal region of
cvfA was amplified by PCR, inserted into the suicide vector pSPC18 (26), and
then used to transform strain HSC5 to resistance to spectinomycin. To ensure
that mutant phenotypes were specifically due to gene disruption and not due to
a nonspecific effect of integration of pSPC18 into the chromosome, S. pyogenes
HSC5Spc was included in selected analyses as a wild-type control strain for
pSPC18 insertion (9). For cis complementation of the disrupted cvfA gene in the
CvfA mutant strain, the CvfA::pCIV2::cvfA strain was constructed as follows.
cvfA containing a putative promoter region was amplified by PCR, inserted into
the suicide vector pCIV2 (32) and then used to transform the CvfA strain.
Suicide vectors, such as pSPC18 and pCIV2, do not have a replication origin of
Streptococcus, so the plasmid can be maintained in Streptococcus only by inte-
grating into the chromosome through homologous recombination. Details on
each integrating plasmid and the sequences of the primers used for amplification
of DNA segments are listed in Table 1. The gene disruption or reconstruction by
homologous recombination was confirmed by PCR using appropriate primers.
RNA isolation and real-time RT-PCR. RNA isolation from S. pyogenes cul-
tures and real-time reverse transcription-PCR (RT-PCR) were conducted as
described elsewhere (4). The primers for real-time PCR were described else-
where (9), except for the primers for gmk expression analysis (GGGTTGATT
ATTTCTTCCGC and AACATAAGTTAAAGGGGTGCC). The level of ex-
pression of the recA gene was used as an internal control to normalize the levels
of expression of specific transcripts in different samples (4). Data reported
represent the mean derived from at least 2 RNA preparations derived from a
minimum of 2 independent experiments, each performed on a different day, and
each data point was determined at least twice.
Microarray analysis. Microarray analysis was conducted as described else-
where (8). Briefly, an antisense oligonucleotide array based on the published
genome of S. pyogenes SF370 (12) was made with a single oligonucleotide (60- to
80-mer) designed to hybridize to the putative transcripts from each annotated
open reading frame (ORF). Synthesis and labeling of cDNA used a commer-
cial kit (3DNA Array 900; Genisphere), and the signal of cyanine 3 (Cy3) or
cyanine 5 (Cy5) was measured using a laser scanner (ScanArray Express HT;
Perkin-Elmer). The fluorescence values from each array were normalized by the
LOWESS (Locally Weighted Scatter plot Smoother) function of the laser scan-
ner. Average values were calculated from a data set consisting of 18 total
microarray hybridizations that were derived from RNA samples prepared from
2 independent experiments, each of which was conducted on a different day. The
data were tested for significance computationally using significance analysis of
microarrays (SAM) software (http://www-stat.stanford.edu/tibs/SAM/) (40)
with the following settings: log2-based transformation of fold change values and
a one-class response format. Genes considered differentially expressed fulfilled
the following criteria: the estimated false discovery rate at the 90th percentile
was 0.1%, and the fold change value was at least 2.0.
Analysis of protein expression. Use of protease indicator medium, Western
blot analysis against SpeB, and SpeB cysteine protease activity were all per-
formed as described previously (25). M protein in cell wall fractions was analyzed
by Western blotting as described previously (9).
Streptokinase activity assay. Streptokinase activity in S. pyogenes culture su-
pernatants was determined by measuring the activity of plasmin activated by
streptokinase as described elsewhere (39). The cysteine protease inhibitor E-64
(final concentration, 10 M; Sigma) was added to S. pyogenes cultures to prevent
degradation of streptokinase by SpeB. Briefly, 20 l of filter-sterilized culture
supernatant, 50 l of 50 mM Tris buffer (pH 8.0), and 50 l of human plasmin-
ogen (20 g/ml) (catalogue no. P-5661; Sigma) were mixed and incubated for 15
min at 37°C. Then, 50 l of a chromogenic plasmin substrate (H-D-valyl-leucyl-
lysine-p-nitroaniline) (1 mg/ml) (catalogue no. V7127; Sigma) was added and
further incubated for 30 min at 37°C. After the final incubation, absorbance at
405 nm was measured. Tests were performed in triplicate.
CAMP test. CAMP factor activity of S. pyogenes strains was tested as described
elsewhere (13). In brief, S. pyogenes strains were streaked perpendicular to, but
not touching, a streak of S. aureus ATCC 25923, which produces a -toxin. THY
medium or C-medium agar plates containing 5% (vol/vol) sheep blood were
used. After anaerobic incubation at 30°C overnight, the plates were inspected for
CAMP hemolysis.
ppGpp measurements. The assay to detect ppGpp was performed as described
previously (28, 36). Briefly, S. pyogenes was grown in CDM supplemented with
0.1% (wt/vol) yeast extract and 26 mM MOPS (morpholinepropanesulfonic acid)
at 37°C to the mid-exponential phase (optical density at 600 nm [OD600] of 0.35).
The cells were washed with phosphate-buffered saline (PBS) buffer, suspended in
1 ml of low-phosphate medium containing 0.07% glucose for carbon source
starvation or 1.0% (wt/vol) glucose, and incubated with 150 mCi carrier-free 32Pi
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for 90 min at 37°C. To determine nucleotide patterns, the cells were resuspended
in 200 l of ice-cold 13 M formic acid. After three freeze-thaw cycles, the
samples were centrifuged, and the supernatant fluids were subjected to one-
dimensional polyethyleneimine (PEI) thin-layer chromatography (TLC) devel-
oped with 1.5 M potassium phosphate solution (pH 3.4). The assay of ppGpp in
E. coli control strains was performed as described elsewhere (11).
Formaldehyde cross-linking to examine the interaction between CvfA and
enolase. To test whether CvfA interacts with enolase (SPy_0731), CvfA was
labeled with the 6	 His tag, and enolase was labeled with hemagglutinin (HA)
tag through homologous recombination. The C-terminal regions of CvfA and
enolase were amplified with the proper primers (Table 1). The primers annealing
to the sense strand (the primers binding to the 3 end) included the sequence of
each tag. Each amplified PCR product was inserted into a suicide vector
(pSPC18 for the PCR product of CvfA C-terminal sequence fused to the 6	 His
tag sequence and pCIV2 for the PCR product of enolase C-terminal sequence
fused to the HA tag sequence) and transferred to S. pyogenes HSC5 sequentially
by electroporation. CvfA was tagged first, and then enolase was tagged. The
strain with both tags was selected through antibiotic resistances conferred by
each suicide vector (spectinomycin resistance from pSPC18 and kanamycin re-
sistance from pCIV2), and proper insertions of the plasmids were examined
through Western blotting using antibody against the His tag (anti-His tag anti-
body) or the HA tag (anti-HA tag antibody).
After both proteins were tagged, we performed protein cross-linking using
formaldehyde, a cleavable and membrane-permeable cross-linker. The strain
that has both proteins tagged was grown in 1 liter of C medium supplemented
with 1% (wt/vol) glucose to the stationary phase (OD600 of 1.2) and washed with
PBS buffer. Then, the cells were suspended in PBS to an optical density at 600
nm of 0.5, and formaldehyde was added to a final concentration of 0.5% (wt/vol).
After the cells were incubated for 20 min at room temperature, the formaldehyde
cross-linking was quenched by adding glycine to a final concentration of 125 mM,
and the cells were extensively washed with PBS buffer to remove residual form-
aldehyde. The cells were then lysed with PlyC, which is the lysin produced by
streptococcal phage C1, in 30% (wt/vol) sucrose solution supplemented with
protease inhibitors (complete, mini, EDTA-free protease inhibitors; Roche Ap-
plied Science). PlyC cleaves the cell wall of S. pyogenes efficiently (31) and makes
protoplasts in 30% sucrose solution. The collected protoplasts were lysed with a
bead beater (FastPrep; MP Biomedicals), and the cell membrane was collected
by ultracentrifugation (100,000 rpm for 12 h). CvfA, which is a membrane-
anchored protein, was released from the membrane by dissolving the membrane
with 4 ml of column binding buffer (50 mM sodium phosphate [pH 7.0], 300 mM
NaCl, 5 mM imidazole) containing 1% (vol/vol) Nonidet P-40 (NP-40), a non-
ionic detergent. The His-tagged CvfA in the dissolved membrane fraction was
then purified with a His tag affinity column containing cobalt resin (Talon His tag
affinity resin; Clontech). After the column was washed with a washing buffer (50
mM sodium phosphate [pH 7.0], 300 mM NaCl, 10 mM imidazole, 1% [vol/vol]
NP-40), the proteins bound to the resin were eluted with 1.0 ml of an elution
buffer (50 mM sodium phosphate [pH 7.0], 300 mM NaCl, 250 mM imidazole)
containing 1% (wt/vol) CHAPS {[(3-cholamidopropyl)dimethylammonio]-1-pro-
panesulfonate}, a dialyzable detergent. It was necessary to add a detergent to the
washing and the elution buffer to prevent aggregation of CvfA inside the affinity
column. The eluted sample was dialyzed to remove salts and detergents and
concentrated to 100 l using a vacuum evaporator. Ten microliters of each
sample was loaded onto a 8% polyacrylamide gel for sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE). Western blotting was per-
formed using anti-His tag antibody or anti-HA tag antibody. Before Western
blotting, the purified proteins were incubated under cross-linker-cleavable or
-noncleavable conditions; boiling for 20 min cleaves protein cross-linking by
formaldehyde.
TABLE 1. Bacterial strains and plasmids used in this study
Strain or plasmid Relevant genotype or description Reference or source
Bacterial strains
E. coli
DH5 recA1 endA1 hsdR17 34





HSC5 Wild type 15
HSC5Spc Wild-type control strain for pSPC18 insertion; pSPC18 was inserted downstream of recF
in the chromosome of strain HSC5 without disrupting any gene or operon
9
CvfA strain HSC5 mutant with cvfA disruption created by pSPC18::cvfAa This study
CvfA::pCIV2::cvfA strain CvfA strain with pCIV2::cvfA insertion in the chromosome; the disrupted cvfA gene
in the CvfA strain was restored by inserting an intact copy of cvfAa
This study
CvfA(pRopB-HA) strain CvfA strain transformed with pRopB-HA This study
Plasmids
pSPC18 pUC18-based streptococcal integration vector containing aad9 (spectinomycin resistance
gene from Enterococcus faecalis)
26
pCIV2 pUC18-based streptococcal integration vector containing aphA3 (kanamycin resistance
gene)
32
pSPC18::cvfA pSPC18 containing a 0.78-kbp internal fragment of cvfA generated by PCR with the
CvfA-f primer (TCCCCGGGAATCTAAACACATTGATGAGCGGC) and the
CvfA-r primer (CGCGGATCCTAATTCTCCATTGACTCATTACG)b
This study
pCIV2::cvfA pCIV2 containing an intact copy of cvfA (1.80 kbp) generated by PCR with the
CvfAcomp-f primer (ACATGCATGCGAAGCCTACATCATGGACGAC) and the
CvfAcomp-r primer (GGGGTACCCTACTTGGCATAATCAACCG)b
This study
pRopB-HA pABG5 derivative containing HA-tagged ropB 24
pSPC18::cvfA-6xHis pSPC18 containing a DNA sequence of the C-terminal part of CvfA fused to the 6	
His tag sequence (0.75 kbp) generated by PCR with the CvfA6xisBam-f primer (TT
TGGATCCTCTCTGATTGCTGATGGTCG) and the CvfA6xHisBam-r primer (TTT
GGATCCTCAATGATGATGATGATGATGCTTGGCATAATCAACCGCTCTC)b
This study
pCIV2::eno-HA pCIV2 containing a DNA sequence of the C-terminal part of enolase (SPy_0731) fused
to the HA tag sequence (0.75 kbp) generated by PCR with the EnoSal-f primer (AA




a See Fig. 1.
b Restriction sites embedded into primer sequences are underlined.
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Murine subcutaneous infection model. The virulence of S. pyogenes strains was
examined using a murine subcutaneous infection model described previously (5).
Briefly, 6- to 8-week-old female SKH1 hairless mice (Charles River Labs) re-
ceived subcutaneous injections of 1 	 107 CFU in 100-l volume into the right
flank. Each study group consisted of 10 mice, and 5 mice were housed together.
The area of the draining ulcer that formed was documented every 24 h by digital
photography, and the precise area of each ulcer was calculated from the digital
record using Meta-Morph image analysis software (version 4.6; Universal Imag-
ing Corp.). Any differences in the areas of ulcers between experimental groups
were tested for significance by the Mann-Whitney U test, and the null hypothesis
was rejected when the P value was 0.05. The pathology of mouse ulcers caused
by S. pyogenes was examined as follows. The lesions that developed on the right
flanks of mice injected with 1 	 107 CFU of S. pyogenes subcutaneously were
removed at 72 h postinjection using a sterile scalpel after euthanasia. Each lesion
removed was fixed by immersion in 10 ml of a commercial tissue fixative (His-
tochoice; Sigma). The fixed samples were routinely processed and then embed-
ded in paraffin, and 5-m-thick sections were prepared which were dewaxed and
rehydrated by standard methods and then stained with hematoxylin and eosin.
The pathology of stained samples was observed and documented with a micro-
scope equipped with digital photography (Leica microscope model DMIRB).
Microarray data accession number. The microarray data have been deposited
in the National Center for Biotechnology Information Gene Expression Omni-
bus (http://www.ncbi.nlm.nih.gov/geo) under GEO Series accession number
GSE15938.
RESULTS
Transposon mutagenesis identified the cvfA gene. We em-
ployed Tn5-based transposome mutagenesis (9) to search for
genes regulating the expression of virulence factors. A trans-
poson insertion library created by transposome mutagenesis
was examined for mutants that displayed reduced activity of
the secreted SpeB cysteine protease following overnight cul-
ture on a protease indicator medium. Sequencing of the trans-
poson insertion loci of mutants identified the Spy_1633 gene,
also known as cvfA. In the transposon-generated cvfA mutant,
transposon insertion occurred at the 3 side of the cvfA gene
(between TA and C of the 517th codon of tyrosine; the total
number of codons in cvfA is 535). To confirm the results of
transposon mutagenesis, we created a CvfA null mutant by
directed insertional mutation using a streptococcal suicide vec-
tor (Fig. 1). An internal fragment of cvfA amplified through
PCR was inserted into pSPC18, a streptococcal suicide vector
that has a spectinomycin resistance gene (aad9) (26), and the
construct was transferred to S. pyogenes HSC5, the wild-type
strain, by electroporation. Strain HSC5Spc, which has pSPC18
inserted in the chromosome without disrupting any gene or
operon, was used as a wild-type control for pSPC18 insertion in
the chromosome (9). Like the transposon-generated mutant,
the CvfA null mutant (CvfA strain) also showed great reduc-
tion of SpeB production (Fig. 2). The growth rate of the CvfA
null mutant was the same as that of the wild-type control in
laboratory media.
To examine whether the disruption of cvfA influences the
transcription of downstream genes, we determined the level of
expression of the first gene downstream, gmk, the direction of
which is the same as that of cvfA. When the expression of gmk
was examined with real-time RT-PCR, the ratio of expression
of the gmk gene in the CvfA mutant to the expression in the
wild-type control was 1.24  0.16 (mean  standard devia-
tion), indicating that cvfA disruption did not affect the expres-
sion of downstream genes (no polar effect).
To perform a complementation test for the disruption of
cvfA, a copy of intact cvfA was introduced into the chromo-
some of the CvfA mutant. The cvfA gene and its putative
promoter region were amplified and inserted into pCIV2, a
streptococcal suicide vector containing a kanamycin resistance
gene (aphA3) (32), and transferred to the CvfA mutant
through electroporation. The introduction of an intact copy of
cvfA through homologous recombination between the cvfA
gene inserted into the second pCIV2 plasmid and the 5 side of
the disrupted cvfA on the chromosome of the CvfA strain
was confirmed by PCR using appropriate primers (Fig. 1). The
complemented strain, the CvfA::pCIV2::cvfA strain, exhib-
ited the same phenotypic characteristics as those of the wild
type, as shown in Fig. 2 (SpeB activity) and Fig. 4 (M-protein
production, streptokinase activity, and CAMP factor activity in
C medium). Thus, the cis complementation of cvfA reverted
the phenotype of the CvfA mutant to that of the wild type,
indicating only cvfA disruption was responsible for the pheno-
type of the transposon-generated cvfA mutant.
The effect of cvfA on virulence gene expression was most
pronounced during stationary phase. The virulence gene ex-
pression of the CvfA mutant was examined at different
FIG. 1. Construction of the CvfA mutant and its cis-comple-
mented strain. The integrational plasmid (pSPC18::cvfA) shown at
the top was used to disrupt the cvfA locus in S. pyogenes HSC5. The
broken ends of the plasmid-encoded box indicate that the cvfA gene
segment lacks the 5 and 3 ends of the corresponding chromosomal
open reading frame, and the region is indicated by the open box above
the cvfA gene. The other integrational plasmid (pCIV2::cvfA) shown in
the middle was used to complement the disrupted cvfA in the CvfA
mutant. Chromosomal structures resulting from the single recombina-
tion event are indicated below the solid vertical arrows. The open
reading frames labeled aad9 and aphA3 encode a spectinomycin-resis-
tant determinant and a kanamycin-resistant determinant, respectively.
acetyl-CoA, acetyl coenzyme A.
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growth stages with real-time RT-PCR and compared with that
of S. pyogenes HSC5spc, the wild-type control strain. RNA was
extracted from the cells grown for 3, 6, or 8 h in C medium
(25). Each time point represents exponential, early stationary,
and stationary growth of cells (Fig. 3). As the length of time of
cultivation increased, the differences in gene expression of the
CvfA mutant and the wild type increased (Fig. 3). The expo-
nentially growing cells at 3 h postinoculation (3 hpi) did not
show much difference in the virulence gene transcript amount,
the early-stationary-phase cells (6 hpi) started to show differ-
ences in the transcript amount, and cells at the stationary
phase (8 hpi) showed the biggest differences in the transcript
amounts of the CvfA mutant and the wild type. At the sta-
tionary growth phase (8 hpi), the expression of the genes en-
coding streptokinase (ska), M protein (emm), CAMP factor
(cfa), streptolysin O (slo), dipeptide ABC transporter sub-
strate-binding protein (dppA), and the MrgA protein (mrgA)
were upregulated, and the expression of the cysteine protease
SpeB gene (speB) was significantly downregulated in the
CvfA mutant compared to the wild type (Fig. 3). Thus, CvfA
downregulates the expression of ska, emm, cfa, slo, dppA, and
mrgA and upregulates the expression of speB at the stationary
phase in wild-type cells in C medium. Taken together, CvfA
differentially regulates the expression of virulence factors
mostly during stationary phase.
Microarray analysis to determine the effect of CvfA on
global gene expression at stationary phase. To gain insight into
the expression of genes affected by CvfA, global transcriptome
profiling between the CvfA mutant and the wild type was
compared through DNA microarray analysis. The design, con-
struction, and validation of the microarray are described in
detail elsewhere (8). Differential expression profiles were de-
veloped by comparing stationary-phase cells (8 hpi) in which
the effect of CvfA on virulence gene expression was most
pronounced (Fig. 3). This analysis revealed large differences in
expression between the CvfA mutant and the wild type. Ap-
proximately 14% of the total number of genes in the genome
were significantly upregulated (219 genes), and 15% were sig-
nificantly downregulated (228 genes) in the CvfA mutant
compared to the wild type (see Tables S1 and S2 in the sup-
plemental material). To gain insight into the overall change,
genes whose expression was altered by CvfA were assigned a
code according to the COG (clusters of orthologous groups)
database (Table 2). Each code of the COG system represents
a basic cellular process, and open reading frames (ORFs) are
assigned to one of the codes based on predicted function by
orthologous relationships (38). In the analysis according to this
system, the genes in the categories of transport and metabo-
lism of most of the cellular components, including amino acids,
carbohydrates, and lipids, were upregulated in the CvfA mu-
tant compared to the wild type (Table 2). Also, the genes in the
category of energy production and conversion were upregu-
lated. On the other hand, the genes in the transcription cate-
gory, which includes the genes of transcriptional regulators,
were downregulated. A number of recognized virulence factors
were differentially expressed in the CvfA mutant than in the
wild type, and this result was confirmed by real-time RT-PCR
(Table 3). The streptokinase (ska), exotoxin G (speG), CAMP
factor (cfa), streptolysin O (slo), and M protein (emm) gene
were upregulated, and the SpeB (speB), mitogenic factor (mf),
and streptolysin S (sagA) genes were downregulated.
The role of CvfA in influencing virulence gene expression
was affected by growth media. The activities or amounts of
protein of three virulence factors (M protein, streptokinase,
and CAMP factor), whose levels of expression were altered in
the CvfA mutant compared to the wild type, were examined
to confirm the results of transcript analyses. As expected, when
S. pyogenes was grown in C medium, which was used for real-
time RT-PCR analysis, the amount of M protein, streptokinase
activity, and CAMP factor activity of the CvfA mutant were
higher than those of the wild type, indicating that CvfA is
involved in the downregulation of these virulence factors in the
wild type in C medium (Fig. 4). However, when S. pyogenes was
grown in THY medium, the amount of M protein, streptoki-
nase activity, and CAMP factor activity of the CvfA mutant
were the same as those of the wild type, indicating that the
CvfA protein does not downregulate these activities in THY
medium (Fig. 4). Transcript analysis performed with real-time
RT-PCR indicated that the altered phenotypic outcomes in
different growth media originated at transcript level (Fig. 5A).
FIG. 2. Contribution of cvfA to SpeB expression. (A) Protease pro-
duction on indicator medium. The wild-type (WT) S. pyogenes strain
(HSC5spc), CvfA mutant strain (CvfA strain), and CvfA comple-
mented strain (Comp.) (CvfA::pCIV2::cvfA) were transferred to pro-
tease indicator medium and examined following overnight incubation.
SpeB activity accounts for more than 95% activity of the secreted
proteases by S. pyogenes. A zone of clearing resulted from protease
activity. (B) Western blot analysis against SpeB. The SpeB cysteine
protease in supernatants of 12-h cultures of strains are shown. Note
that multiple proteolytic cleavages are required for activation of the
46-kDa SpeB zymogen to the active, 28-kDa SpeB. Lane S, protein
size markers. (C) Quantitative assessment of protease activity. The
SpeB cysteine protease activities in supernatants of 12-h cultures
are shown relative to that of the wild-type strain. The data are the
means  standard errors of the means (SEs) derived from at least
three independent experiments.
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The emm, ska, and cfa transcript ratios of the CvfA mutant to
the wild type (CvfA/HSC5Spc) in C medium were much
higher than the ratios in THY medium.
Glucose supplementation to C medium made the phenotype
of the CvfA mutant similar to that of the wild type. A major
difference between THY medium and C medium is the amount
of carbohydrates. C medium consists of 0.5% (wt/vol) proteose
peptone no. 3 (Difco), 1.5% (wt/vol) yeast extract (Difco), 10
mM K2HPO4, 0.4 mM MgSO4, and 17 mM NaCl (pH 7.5).
Unlike THY medium, C medium does not contain glucose, so
it is rich in peptides and poor in carbohydrates. When glucose
(1%, wt/vol) was added to C medium, the emm, ska, and cfa
transcript ratios in the CvfA mutant to the wild type (CvfA/
HSC5Spc) were greatly reduced, so the behavior of the CvfA
mutant in the glucose-supplemented C medium was similar to
that in THY medium (Fig. 5B). This outcome resulted from
decreased expression of most of these genes by glucose in the
CvfA mutant. In glucose-supplemented C medium, the ex-
pression of these virulence genes in both the wild type and the
CvfA mutant increased, but the degree of increase was much
less in the CvfA mutant than in the wild type: 5-fold less for
emm, 55-fold less for ska, and 6-fold less for cfa (Fig. 5C).
Thus, the expression of these virulence genes in the CvfA
mutant was less affected by the addition of glucose compared
to the wild type. Overall, adding glucose to C medium reduced
the difference in virulence gene expression between the CvfA
mutant and the wild type because the response of the CvfA
mutant to glucose was less sensitive than that of the wild type.
This result suggests that a CvfA-involved regulatory system
directly or indirectly senses the amount of glucose in medium
and regulates the expression of some virulence genes by con-
trolling the amount of their transcripts.
The expression of CvfA in the wild type in C medium with or
without glucose did not change; the ratio of cvfA transcript of
cells grown in glucose-supplemented C medium to that in C
medium was 0.84  0.08 (mean  standard deviation), indi-
cating that the amount of cvfA transcript itself was not affected
by the addition of glucose to C medium.
Effect of the supplementation of peptides or sugars (mono-
saccharides) on virulence gene expression regulated by CvfA.
To test whether the addition of peptides to the medium affects
the CvfA-involved regulation of virulence gene expression, the
expression of emm, ska, cfa, and speB in the CvfA mutant and
the wild type in a chemically defined medium (43) supple-
mented with peptides (1%, wt/vol) was compared. In the chem-
ically defined medium supplemented with peptides, the ratio of
emm, ska, or cfa transcript of the CvfA mutant to that in the
wild type did not change (Fig. 6A). However, the speB tran-
script in the CvfA mutant increased 100-fold up to the wild-
type level in the peptide-supplemented chemically defined me-
dium (Fig. 6A), indicating that the CvfA-involved regulatory
system in the wild type downregulates the expression of speB
by responding to the added peptides.
When the amount of glucose increased to 1.0% (wt/vol) in
the chemically defined medium, glucose downregulated the
expression of the emm, ska, and cfa virulence genes in the
CvfA mutant compared to the wild type, as in the glucose-
supplemented C medium (Fig. 5B and 6A). However, the speB
expression ratio was not changed by glucose supplementation
(Fig. 6A).
FIG. 3. Disruption of cvfA results in altered patterns of virulence gene expression at stationary phase. The relative levels of the transcripts of
virulence genes in the CvfA mutant (CvfA strain) were determined over the course of growth in C medium using real-time RT-PCR and
expressed as changes relative to the levels in the wild-type (WT) strain. Levels that were not determined are indicated by an asterisk. The growth
pattern of S. pyogenes is shown in the graph in the inset, and the growth stage of each sampling time is shown as indicated. The samples were taken
at exponential growth phase at 3 h postinoculation (hpi), early stationary phase at 6 hpi, and stationary phase at 8 hpi. For clarity, only the growth
pattern of the wild-type strain is shown, as the growth characteristics of the two strains were indistinguishable under these conditions. Amt, amount.
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We also tested the effects of other sugars on the expression
of virulence genes in the CvfA mutant and the wild type by
examining the expression of the emm gene and the speB gene.
When a monosaccharide other than glucose, such as fructose,
galactose, or mannose, was added to the chemically defined
medium, overall, the effects of these sugars on the expression
of the emm and speB genes were similar to those of glucose
(Fig. 6B). The addition of sugar to the medium made the ratio
of emm transcript in the CvfA mutant to that in the wild type
smaller. The ratio was even smaller in media supplemented
with galactose or mannose than in media supplemented with
glucose or fructose. The addition of glucose, fructose, or ga-
lactose gave similar speB transcript ratios of the CvfA mutant
to the wild type, but adding mannose gave a smaller ratio than
TABLE 2. Genes that were significantly upregulated or downregulated in the CvfA mutant compared to the wild-type control strain
Code Categorya (no. of genes in categoryb)









J Translation (140) 36 (25.7) 29 (20.7) 1.2
K Transcription (93) 9 (9.7) 22 (23.7) 0.4
L Replication, recombination, and repair (95) 13 (13.7) 18 (18.9) 0.7
C Energy production and conversion (57) 17 (29.8) 7 (12.3) 2.4
E Amino acid transport and metabolism (99) 19 (19.2) 8 (8.1) 2.4
F Nucleotide transport and metabolism (59) 6 (10.2) 7 (11.9) 0.9
G Carbohydrate transport and metabolism (124) 25 (20.2) 16 (12.9) 1.6
H Coenzyme transport and metabolism (34) 4 (11.8) 5 (14.7) 0.8
I Lipid transport and metabolism (45) 8 (17.8) 3 (6.7) 2.7
Q Secondary metabolite biosynthesis, transport, and catabolism (11) 2 (18.2) 1 (9.1) 2.0
D Cell cycle control, mitosis, and meiosis (16) 2 (12.5) 3 (18.8) 0.7
M Cell wall/membrane biogenesis (64) 6 (9.4) 7 (10.9) 0.9
O Posttranslational modification, protein turnover, chaperones (50) 7 (14.0) 6 (12.0) 1.2
P Inorganic ion transport and metabolism (58) 8 (13.8) 7 (12.1) 1.1
T Signal transduction mechanisms (37) 3 (8.1) 7 (18.9) 0.4
U Intracellular trafficking and secretion (14) 4 (28.6) 1 (7.1) 4.0
V Defense mechanisms (36) 2 (5.6) 9 (25.0) 0.2
R General function prediction only (137) 17 (12.4) 20 (14.6) 0.9
S Function unknown (126) 7 (5.6) 25 (19.8) 0.3
Not in COGs (222) 24 (10.8) 27 (12.2) 0.9
Sum (1,517) 219 (14.4) 228 (15.0)
a Genes were categorized according to a functional classification, COGs (clusters of orthologous groups) (38).
b Structural RNA genes (tRNA and rRNA) and phage genes were not included.
c Number of genes displaying statistically significant differential expression fulfilling the following criteria: average fold change of at least 2.0, and FDR (false
discovery rate) in SAM (significance analysis of microarrays) analysis (40) with 90th percentile of  0.1%.
d Number of statistically significant genes to the total number of genes assigned to the category.
TABLE 3. Virulence factors significantly upregulated or downregulated in the CvfA mutant compared to the wild-type control strain
Locusa Geneb Gene productb Fold change bymicroarrayc
Fold change by
real-time PCRd
SPy-1979 ska Streptokinase A precursor 9.28 21.8  4.6
SPy-0212 speG Exotoxin G precursor 6.24 ND
SPy-1273 cfa CAMP factor 5.29 14.2  4.0
SPy-0167 slo Streptolysin O precursor 3.82 4.8  0.8
SPy-0378 hlyX Putative hemolysin 3.76 ND
SPy-2018 emm M protein (type 1) 3.74 14.5  7.3
SPy-1054 Putative collagen-like protein 3.65 ND
SPy-0591 Putative protease 2.63 ND
SPy-1896 ropA Transcription regulator (trigger factor, prolyl isomerase) 2.48 ND
SPy-0165 nga or spn Nicotine adenine dinucleotide glycohydrolase precursor 2.43 ND
SPy-2025 isp Immunogenic secreted protein precursor 2.53 1.1  3.1
SPy-2043 mf Mitogenic factor 3.17 3.6  0.2
SPy-0738 sagA Streptolysin S-associated protein 4.36 2.3  0.6
SPy-2039 speB Pyrogenic exotoxin B 130.54 76.7  84.3
a SPy numbers are assigned on the basis of the genome of serotype M1 group A streptococcus (GAS) strain SF370 (12).
b Assignment based on annotation of serotype M1 GAS strain SF370 ORFs (http://www.ncbi.nlm.nih.gov/genomes/altik.cgi?gi178&dbGenome).
c Average of a data set consisting of 18 total microarray hybridizations with 2 independently prepared RNA samples. The values here fulfilled the following criteria:
the estimated false discovery rate at the 90th percentile in SAM (significance analysis of microarrays) analysis (40) was 0.1%, and the fold change value was at least
2.0.
d Fold change determined by real-time RT-PCR. Data show mean  standard deviation derived from at least two independent experiments. ND, not determined.
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the other sugars. Mannose gave the largest effect among the
sugars tested and showed the result that was most opposite the
effect of peptide supplementation.
Taken together, these data suggest that the CvfA-involved
regulatory system regulates the expression of two sets of viru-
lence genes in different ways: the expression of a set of genes
such as emm, ska, and cfa is affected by sugars (possibly carbon
sources), and the expression of the other set of genes, including
speB, is influenced more by peptides (possibly nitrogen
sources). When sugar is depleted, the CvfA-involved regula-
tory system downregulates the expression of the emm, ska, and
cfa genes. When peptides are depleted, the CvfA-involved
regulatory system upregulates the expression of speB, but the
levels of expression of the emm, ska, and cfa genes are not
changed much. Thus, the CvfA-involved regulatory system
seems to sense nutrients in the environment or sense cellular
metabolic status to differentially regulate the expression of
streptococcal virulence genes.
Overexpression of the transcriptional regulator RopB in the
CvfAmutant restored SpeB production to the wild-type level.
In S. pyogenes, transcription of speB is under the control of the
transcriptional regulator RopB (30). To test whether CvfA
influences SpeB production via the transcription regulator
RopB, the CvfA mutant was transformed with a plasmid that
expresses high levels of a functional RopB protein that has
been modified to include an influenza virus HA tag at its
carboxy terminus (24). The CvfA mutant in which RopB was
overexpressed secreted the same level of SpeB protein as the
wild type did (Fig. 7), indicating that CvfA influences SpeB
expression via RopB.
The nutrient-dependent virulence gene regulation by the
CvfA-involved regulatory system was not caused by the
ppGpp-mediated stringent response. The nutrient-dependent
virulence gene expression through CvfA was suggestive of the
stringent response. The stringent response is triggered by the
accumulation of guanosine nucleotides, mainly guanosine tet-
raphosphate (ppGpp) to conserve energy when microorgan-
isms face nutrient starvation especially on glucose or amino
acids. Also, CvfA contains an HD domain like the streptococ-
cal RelA enzyme, a bifunctional ppGpp synthetase/hydrolase.
Thus, we compared the patterns of ppGpp production in the
CvfA mutant and the wild type under glucose starvation
conditions to investigate whether the phenotype of the CvfA
mutant is caused by the stringent response. However, the
ppGpp accumulation patterns in the CvfA mutant and the
wild type under glucose starvation conditions were identical
(Fig. 8), indicating that the ppGpp-mediated stringent re-
sponse is not involved in the phenotype of the CvfA mutant.
CvfA interacts with enolase, an enzyme in the glycolysis
pathway. Recent studies indicated that the CvfA ortholog in B.
FIG. 4. Biochemical assay to confirm the results of transcript analysis. The wild-type (WT) strain (HSC5spc), CvfA mutant strain (CvfA
strain), and CvfA complemented strain (Comp.) (CvfA::pCIV2:: cvfA) were used. The CvfA mutant exhibits a phenotype different from that
of the wild type only in C medium, not in THY medium. (A) Western blot against M protein. The amounts of M protein in cell wall fractions were
compared by Western blotting. The cysteine protease inhibitor E-64 (final concentration, 10 M) was added to S. pyogenes culture to prevent the
degradation of M protein by SpeB. (B) Streptokinase activity. The activities of streptokinase in the supernatants of cultures 3, 6, and 8 h
postinoculation were analyzed and expressed relative to the activity in supernatant of the wild-type culture 8 h postinoculation. The data are the
means and standard errors of the means derived from at least three independent experiments. The cysteine protease inhibitor E-64 (final
concentration, 10 M) was added to S. pyogenes culture to prevent the degradation of streptokinase by SpeB. (C) CAMP test. CAMP factor activity
was measured by streaking S. pyogenes strains perpendicular to a streak of S. aureus producing -toxin on agar plates containing C medium or THY
medium and 5% (vol/vol) sheep blood. CAMP factor activity was expressed relative to the activity of the wild type. The CAMP factor activities
were compared by measuring the area of CAMP hemolysis zone using ImageJ software (NIH) after the plates were scanned. The data are the
means and standard errors of the means derived from at least two independent experiments.
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subtilis has endoribonuclease activity and interacts with the
RNA processing enzymes RNase J1 and polynucleotide phos-
phorylase and with the glycolytic enzymes phosphofructoki-
nase and enolase (10, 35). Because the CvfA-involved regula-
tion controls the expression of streptococcal genes according
to nutritional status, we examined whether CvfA interacts with
enolase (Spy_0731), one of the glycolytic enzymes interacting
with the B. subtilis CvfA ortholog, in S. pyogenes. For the test,
we tagged CvfA with the 6	 His tag and enolase with the HA
(hemagglutinin) tag at their C termini through homologous
recombination. After we tagged CvfA with the 6	 His tag, we
analyzed the cysteine protease SpeB activity in culture super-
natant to examine whether the tagged CvfA is functional, since
the CvfA CvfA mutant strain showed prominent reduction
in SpeB production (Fig. 2). The SpeB activity did not change
after CvfA was tagged with 6	 His (data not shown), indicat-
ing that the His-tagged CvfA was functional. Enolase in B.
subtilis is essential even under conditions when no glucogenic
activities are required (10). We could tag enolase in S. pyogenes
with the HA tag, suggesting that the enolase tagged with the
HA tag was functional. After both proteins were tagged, we
performed protein cross-linking using formaldehyde, a cleav-
able and membrane-permeable cross-linker. CvfA is a mem-
brane-anchored protein, so a detergent, ND-40, was used to
purify CvfA, and this usage of a detergent made us employ a
chemical cross-linking strategy for the protein interaction
study. Cross-linking was performed with a 0.5% (wt/vol) form-
aldehyde solution for 20 min at room temperature. Then, CvfA
FIG. 5. Glucose influences virulence gene expression through
CvfA. The amounts (Amt) of transcripts of the genes encoding M
protein (emm), streptokinase (ska), and CAMP factor (cfa) in S. pyo-
genes strains at the stationary phase (8 h postinoculation) were deter-
mined by real-time RT-PCR. The S. pyogenes strains used were the
wild-type strain (WT) (HSC5spc) and the CvfA mutant strain
(CvfA strain). (A) The ratio of emm, ska, or cfa transcript of the
CvfA mutant to that in the wild type (CvfA/WT) for cells grown in
C medium or THY medium is shown. The ratios became smaller in
THY medium, which contains glucose, unlike C medium. (B) The ratio
of emm, ska, or cfa transcript in the CvfA mutant to that in the wild
type (CvfA/WT) for cells grown in C medium or C medium supple-
mented with 1% (wt/vol) glucose (C mediumGlc) is shown. The
ratios became smaller when glucose was added to the medium. (C) The
ratio of emm, ska, or cfa transcript for the wild-type or CvfA mutant
cells grown in C medium supplemented with 1% (wt/vol) glucose to
transcript for cells grown in C medium (C mediumGlc/C medium) is
shown. The ratios for the CvfA mutant were smaller than those for
the wild type.
FIG. 6. Effect of supplementing the medium with peptides or sug-
ars on the expression of virulence genes regulated by CvfA. The wild-
type (WT) strain (HSC5spc) and CvfA mutant strain (CvfA strain)
were used. (A) Glucose influences the expression of emm, ska, and cfa,
and peptides influence the expression of speB through CvfA. The
amounts (Amt) of transcripts of the genes encoding M protein (emm),
streptokinase (ska), CAMP factor (cfa), and streptococcal pyrogenic
exotoxin B (speB) in the CvfA mutant were determined by real-time
RT-PCR and expressed relative to those of the wild type (CvfA/WT).
The cells were grown to the stationary phase (8 h postinoculation) in
chemically defined medium containing glucose (0.05% or 1.0% [wt/
vol]) as a carbohydrate source and/or dialyzed proteose peptone (1.0%
[wt/vol]) as a supplemented peptide source. (B) Supplementation with
fructose, galactose, or mannose gave results similar to the results of
supplementation with glucose on the expression of the emm and speB
genes regulated by CvfA. The amounts of transcripts of the genes
encoding M protein (emm) and streptococcal pyrogenic exotoxin B
(speB) in the CvfA mutant were determined by real-time RT-PCR
and expressed relative to those of the wild type (CvfA/WT). The cells
were grown to the stationary phase (8 h postinoculation) in chemically
defined medium containing glucose (0.05% or 1.0% [wt/vol]), fructose
(1.0% [wt/vol]), galactose (1.0% [wt/vol]), or mannose (1.0% [wt/vol])
as a carbohydrate source. Abbreviations: Glc, glucose; Gal, galactose;
Fru, fructose; Man, mannose; dPP, dialyzed proteose peptone.
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tagged with the 6	 His tag was purified with a His tag affinity
resin, and the purified proteins were applied to Western blots
to see whether enolase was copurified under this condition.
The purified proteins were treated in a cross-linking cleavable
or noncleavable condition before they were applied to Western
blots. Protein cross-linking by formaldehyde can be cleaved by
boiling samples for 20 min. In the noncleavable condition of
formaldehyde cross-linking, three high-molecular-mass bands
with a mass of more than 100 kDa were detected when anti-His
tag antibody, which detects the His-tagged CvfA, was used.
This indicates that CvfA (size, 60.3 kDa) is interacting with
itself or other proteins inside cells (Fig. 9A). The three high-
molecular-weight protein bands in the same sample disap-
peared in the cross-linking cleavable condition, indicating that
the high-molecular-weight bands containing CvfA are products
of formaldehyde cross-linking. When Western blotting was
performed with the purified proteins in the noncleavable con-
dition using anti-HA tag antibody, which detects the HA-
tagged enolase, the same three high-molecular-weight protein
bands were detected, and no enolase band was detected (Fig.
9B). In the cross-linking cleavable condition, only the protein
band of enolase (47.4 kDa) was detected. These results indi-
cate that there was no contamination by free enolase while
His-tagged CvfA was purified, and all enolase in the purified
sample was cross-linked with CvfA directly or indirectly. In
conclusion, the interaction between CvfA and enolase was
detected in S. pyogenes.
The CvfA mutant is highly attenuated in a murine model
of soft tissue infection. To test whether cvfA disruption alters
the virulence of S. pyogenes in a subcutaneous infection model,
a dose (1 	 107 CFU) of the wild type or the CvfA mutant
was subcutaneously injected into SKH1 hairless mice. For the
strain used in this study (HSC5), injection into the subcutane-
ous tissue of an SKH1 hairless mouse results in a local draining
ulcer, whose area reaches the maximum value 3 days postin-
fection and which then goes on to heal over the next 10 to 14
days (5). For this study, 10 mice were injected with each S.
pyogenes strain, and the sizes of the lesions were measured
every day. The CvfA mutant produced significant smaller
lesions than the wild type did on day 3 postinjection (Fig. 10A).
Histological examination of the lesions clearly showed that
destruction of mouse tissue infected with the CvfA mutant
was much milder than that infected with the wild type (Fig.
10B), even though the sizes of abscess cavities caused by the
injection of the wild type and the CvfA mutant were the
same. The subcutaneous tissue and the muscle layer right be-
low the subcutaneous tissue (Fig. 10B1 and 3) showed less
destruction by the CvfA mutant infection than by the wild-
type infection. Also, a clearer barrier between the ulcer and
tissue was observed in the lesion caused by infection with the
FIG. 7. Overexpression of RopB restores SpeB expression in the
CvfA mutant. (A) Western blot analysis to detect SpeB in S. pyogenes
strains containing a plasmid that overexpresses RopB (pRopB-HA) or
in S. pyogenes strains without the plasmid. The wild-type (WT) S.
pyogenes strain (HSC5spc) and CvfA mutant strain (CvfA strain)
were used. Note that multiple proteolytic cleavages are required for
activation of the 46-kDa SpeB zymogen to the 28-kDa active protease.
S, protein size markers. (B) The SpeB cysteine protease activities in
supernatants from 12-h cultures are shown relative to that of the
wild-type strain.
FIG. 8. The ppGpp accumulation pattern of the CvfA mutant
under glucose starvation conditions is not different from that of the
wild type. (A) ppGpp accumulation in S. pyogenes strains. The wild-
type (WT) strain (HSC5spc) and CvfA mutant strain (CvfA strain)
were used. The cells were labeled with [32P]H3PO4 in MOPS under
glucose-rich (1.0%, wt/vol) or glucose-starved (0.07%) condition. Nu-
cleotides were acid extracted, and 32Pi-labeled nucleotides were re-
solved by polyethyleneimine-coated TLC plates followed by autora-
diography. (B) ppGpp accumulation in E. coli control strains under
glucose-starved conditions. E. coli strains CF1648 (wild type) and
CF1693 (RelA SpoT) were used.
FIG. 9. CvfA interacts with enolase. Western blotting against CvfA
(A) or enolase (B) after in vivo cross-linking with formaldehyde (FA).
The S. pyogenes strain that has both 6	 His-tagged CvfA and HA-
tagged enolase was treated with formaldehyde (), and CvfA was
purified with His tag affinity resin. The presence of CvfA and enolase
in the sample was then determined through Western blotting using
anti-His tag antibody (A) or anti-HA tag antibody (B). Enolase was
detected when CvfA was purified, and this copurification indicates the
interaction between CvfA and enolase. The cross-linking between pro-
teins by formaldehyde can be cleaved by boiling samples (). The
positions of cross-linking products (X-linking products), CvfA, and
enolase (ENO) are shown to the right of the blots.
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CvfA mutant than in the lesion caused by infection with the
wild-type strain (Fig. 10B2). Thus, cvfA disruption attenuated
the virulence of S. pyogenes in a self-limited soft tissue infection
model as well as in a lethal intraperitoneal systemic infection
model (17).
DISCUSSION
In this study, the effect of CvfA on the expression of S.
pyogenes genes was examined under different conditions. Mi-
croarray analysis revealed that 29% of the total number of
genes in the genome was significantly up- or downregulated by
CvfA, indicating that CvfA extensively affects the expression of
genes in S. pyogenes. The effect of CvfA on virulence gene
expression was affected by growth phase and medium compo-
nents. CvfA represses the expression of a set of virulence genes
such as emm, ska, and cfa in medium containing minimal
amounts of carbohydrates and activates speB gene expression
in medium containing minimal amounts of peptides (Fig. 11).
Thus, CvfA appears to respond to carbon and nitrogen sources
to regulate the expression of S. pyogenes virulence genes.
The effect of CvfA on the expression of many virulence
genes in S. pyogenes was altered depending on the cell growth
phase (Fig. 3). Previously, it has been shown that the expres-
sion of most virulence factors of S. pyogenes is influenced by
growth phase (21, 41). Growth phase status may be sensed as
a result of the change of environment by metabolic by-products
or nutrient consumption (36, 37), as cell cycle status (33), or as
population densities (45). The growth-phase dependence of
gene regulation by CvfA could be due to the lack of carbon or
FIG. 10. The CvfA mutant is highly attenuated. (A) The ability of the CvfA mutant to cause disease in the murine subcutaneous infection
model was determined. Virulence was evaluated on the basis of the area of the ulcer produced at the time when ulcer formation was maximal in
the wild-type strain (3 days postinfection). Each symbol represents the area of the ulcer in an individual mouse infected with the wild type or the
CvfA mutant, and the solid bars indicate the mean values for the strains. The wild-type (WT) strain (HSC5spc) and CvfA mutant strain (CvfA
strain) were used. The P value for the means determined by a Mann-Whitney U test statistic is indicated above the bracket. (B) Microscopic
appearance of mouse ulcers caused by the wild type or the CvfA mutant. The ulcers that developed were removed at 3 days postinfection, fixed
and processed by standard methods, and stained with hematoxylin and eosin. Images were taken with a microscope equipped with digital
photography. Three local images from each ulcer were taken, and each number above the images (1, 2, or 3) matches the number in the whole-ulcer
image. (C) An example of microscopic appearance of the whole ulcer formed by S. pyogenes infection. Abscess cavity by S. pyogenes injection is
formed between the muscle layer under the subcutaneous tissue and fascia.
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nitrogen sources at the stationary phase because the expression
of virulence genes was also influenced by CvfA when carbohy-
drates or peptides are scarce.
Even though the fact that the CvfA-involved regulation of
virulence gene expression is influenced by nutritional stress
and cell growth phase implies the involvement of the ppGpp-
mediated stringent response, this study showed that the regu-
lation by the CvfA-involved regulatory system is not involved in
the stringent response, because the pattern of ppGpp produc-
tion in the CvfA mutant and the wild type under glucose
starvation conditions did not change (Fig. 8). Also, CcpA, the
major carbon catabolite protein, seems not to be involved in
the CvfA-involved regulatory system. The transcriptome anal-
ysis showed that the transcript amount of the ccpA gene in the
CvfA mutant was the same as that in the wild type, indicating
that the CvfA-mediated regulatory system does not affect the
expression of ccpA. Also, the expression of SpeB in a CcpA
mutant was almost the same as that in the wild type in C
medium (18), but SpeB expression in the CvfA mutant was
negligible. Thus, the CvfA-mediated regulation of virulence
gene expression in S. pyogenes seems to be a novel way to
control gene expression under nutrient-deficient conditions.
YmdA, the CvfA ortholog in B. subtilis, which shows 56%
identity and 76% sequence similarity to S. pyogenes CvfA in
amino acid level, is copurified with the glycolytic enzymes
enolase and phosphofructokinase (PFKase) (10). We also ver-
ified in this study that CvfA interacts with enolase in S. pyo-
genes. Thus, the interactions between CvfA and the glycolytic
enzymes might play a role in the regulation of gene expression
according to the nutritional condition of cells by transmitting a
signal from the glycolysis pathway to CvfA.
YmdA, the CvfA ortholog in B. subtilis, is responsible for the
endonucleolytic processing of the gapA operon mRNA, which
encodes six genes in the glycolytic pathway (cggR, gapA, pgk,
tpiA, pgm, and eno) (10). YmdA cleaves the gapA operon
between cggR and gapA. S. pyogenes, however, does not have
the gapA operon. The glycolytic enzyme genes in the B. subtilis
gapA operon are scattered throughout the genome of S. pyo-
genes. In our transcriptome analyses, however, the transcripts
of many glycolytic enzymes are reduced by CvfA at the sta-
tionary phase: glucose-6-phosphate isomerase (Spy0215, 6.9-
fold reduction), 6-phosphofructokinase (Spy1283, 2.3-fold re-
duction), enolase (Spy0731, 2.7-fold reduction), pyruvate
kinase (Spy1282, 2.5-fold reduction), and L-lactate dehydroge-
nase (Spy1151, 2.2-fold reduction). Thus, this reduction might
indicate that even though S. pyogenes does not have the gapA
operon, CvfA in S. pyogenes still affects the glycolysis pathway
by regulating the expression of glycolytic enzymes, and the
CvfA-interacting enolase, a key glycolytic enzyme, might be
involved in the regulation of expression of glycolytic enzymes.
The virulence of the CvfA mutant was highly attenuated in
the model of soft tissue infection, indicating that the expression
of virulence genes in the CvfA mutant was misregulated in
soft tissue. Virulence gene expression in the CvfA mutant was
highly misregulated in stationary-phase cultures grown on C
medium, but not in exponential-phase cultures grown on C
medium or in cultures grown on THY medium, so it seems that
the environment of stationary-phase culture in C medium is
similar to the soft tissue environment. Loughman and Caparon
employed the same soft tissue infection model and compared
the gene expression of several S. pyogenes virulence factors in
the tissue environment against the expression in different me-
dia and growth phases, and the gene expression profile of
stationary-phase cultures grown on C medium was most similar
to the profile in the tissue environment (21).
Our transcriptome analyses showed that in nutrient-limited
conditions, CvfA downregulated the expression of most of the
genes encoding cellular components in the categories of trans-
port and metabolism and the genes in the category of energy
production and conversion but upregulated the expression of
some virulence factors, such as SpeB (protease), streptolysin S
(hemolysin), and mitogenic factor (DNase). These virulence
factors are able to destroy cells (streptolysin S) or degrade host
cellular components (SpeB against proteins and mitogenic fac-
tor against nucleic acids). These data suggest that in nutrition-
ally unfavorable conditions, the CvfA-involved regulatory sys-
tem in S. pyogenes, a multiple-auxotrophic human pathogen,
not only decreases cellular metabolism but also increases the
expression of some virulence factors to obtain essential cellular
components such as amino acids and nucleotides.
It has been shown that the CvfA orthologs in Bacillus subtilis
and Staphylococcus aureus have endoribonuclease activity (29,
35). CvfA orthologs contain two functional domains, a KH
domain, which has RNA binding activity (42), and an HD
domain known to have metal-dependent phosphohydrolase ac-
tivity (2). The HD domain in the S. aureus CvfA protein has
manganese ion (Mn2)-dependent phosphodiesterase activity,
which is able to cleave phosphodiester bonds in nucleic acids
and 2,3-cyclic nucleotides (29). KH domains consist of ap-
proximately 70 amino acids and bind RNA or single-stranded
DNA (ssDNA). Proteins containing KH domains are found in
archaea, bacteria, and eukaryota and involved in a myriad of
FIG. 11. Schematic representation of the role of the CvfA-enolase
complex in the regulation of virulence gene expression in S. pyogenes.
The large gray half circle represents an S. pyogenes cell, and a CvfA-
enolase complex is attached to the membrane inside the cell. The lines
from outside of the cell represent the status of the nutritional condi-
tion affecting CvfA-involved regulation (concentrations of carbohy-
drates or peptides), and the lines inside the cell indicate the effect of
the CvfA-involved regulatory system on the expression of virulence
genes. Each type of line (solid black, broken line, and solid gray)
outside and inside the cell match each other. For the lines inside the
cell, arrowheads indicate activation, flat ends reflect repression, and
plain lines with no arrowhead or flat end indicate no effect by the
CvfA-enolase complex. Overall, the CvfA-involved regulatory system
represses the expression of emm, ska, and cfa in low-carbohydrate
conditions and activates the expression of speB in low-peptide condi-
tions.
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different biological processes, including splicing, transcrip-
tional regulation, and translational control (42). KH domains
are classified into two types. Type I domains are found in
multiple copies in eukaryotic proteins, whereas type II KH
domains, like the one in CvfA, are typically found in a single
copy in prokaryotic proteins. Unlike other RNA recognition
motifs, which recognize diverse RNA lengths, the typical bind-
ing surface of KH domains is a cleft that can typically accom-
modate only four consecutive unpaired bases, so a KH domain
usually has broad substrate specificity. Consistent with this
notion, the depletion of the CvfA ortholog in B. subtilis in-
creases the half-life of bulk mRNA more than 2-fold (35).
However, even though CvfA is an endoribonuclease with
broad substrate specificity, the specificity of the KH domain in
CvfA does not seem to be totally nonspecific and bacteria seem
to use the CvfA activity for specific cellular events. For exam-
ple, the B. subtilis CvfA ortholog is involved in the processing
of RNA of the glycolytic gapA operon, which cleaves between
the cggR and gapA transcripts in order to separate their levels
of expression (10). Also, the ortholog initiates the degradation
of all 11 SAM-dependent riboswitches only when the tran-
scripts containing the riboswitch are prematurely terminated
by binding to SAM, but the riboswitches in antiterminated
full-length mRNAs are not cleaved (35). This differential spec-
ificity indicates that the base-pairing status of the four bases
recognized by CvfA can contribute to the substrate specificity
of CvfA.
The E. coli RNA degradosome is composed of RNase E
endoribonuclease, PNPase exoribonuclease, RhlB RNA heli-
case, and enolase glycolytic enzyme (for a review, see reference
7). B. subtilis CvfA also interacts with glycolytic enzymes eno-
lase and PFKase and nucleases PNPase and RNase J1 (10).
These interactions suggest that CvfA could be a member of the
RNA degradosome in Firmicutes (10). Members of the phylum
Firmicutes do not have an RNase E homolog, which is the
major endoribonuclease in the E. coli RNA degradosome, so
CvfA might be a functional homolog of E. coli RNase E (10).
The role of enolase in the RNA degradosome is not known,
but it has been speculated that it is a sensor for the cellular
nutritional status (7), so the presence of enolase might explain
the dependence of the activity of the CvfA-involved regulatory
system on cellular nutritional status. Like CvfA, S. pyogenes
PNPase is also involved in the regulation of expression of some
virulence genes, indicating that RNA decay by RNases is in-
volved in the regulation of virulence gene expression. S. pyo-
genes PNPase is a major factor to control the decay of the
transcripts of the streptolysin S gene (sagA) and the
streptodornase gene (sda) (3). The stability of those mRNAs
was greater in a PnpA mutant, while the stability of mRNAs
of other virulence genes, such as the capsule synthetase gene
(hasA) and the streptolysin O gene (slo), was not affected.
In the microarray analysis, 14% of the total number of genes
in the genome were significantly upregulated (219 genes), and
15% were significantly downregulated (228 genes) in the
CvfA mutant compared to the wild type. A simple explana-
tion for overexpressed transcripts in the CvfA mutant is that
CvfA degrades the RNA or their transcriptional activator
mRNA. In the case of the transcripts whose amount was de-
creased in the CvfA mutant, CvfA might degrade (i) the
mRNA of the transcripts’ direct repressors, (ii) the mRNA of
repressors of the transcripts’ transcription activators, or (iii)
the mRNA of inhibitors to inhibit the transcripts’ activator
activity. The transcription of SpeB, whose transcript was down-
regulated in the CvfA mutant, is activated by the transcrip-
tional regulator RopB. When we introduced the ropB gene into
the CvfA mutant using a multicopy plasmid, the introduction
of ropB rescued the production of SpeB (Fig. 7), indicating that
there was no or much less RopB available for the activation of
speB transcription in the CvfA mutant compared to that in
the wild type. This result suggests that the mRNA of a tran-
scriptional repressor or of a protein inhibitor binding to RopB
might be less degraded in the CvfA mutant. At this time, no
transcriptional repressor of RopB is known, but a protein in-
hibitor of RopB exists. LacD.1, an aldolase enzyme that has
been adapted to function exclusively as a regulatory compo-
nent (22, 23), is known to inhibit speB transcription activation
by RopB through direct binding to RopB (22).
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